World News | Reuters | Wednesday September 30, 2020
Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.
www.ndtv.com